Psilocybin mushrooms for psychological and existential distress | The College of Family Physicians of Canada
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches - Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths, 2021
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches - Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths, 2021
How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans | bioRxiv
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches - Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths, 2021
N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD | CBC News
Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows
Pharmaceuticals | Free Full-Text | Rediscovering Psilocybin as an Antidepressive Treatment Strategy
Johns Hopkins Scientists Give Psychedelics the Serious Treatment - Scientific American
Video: Psilocybin and Mystical Experience: Implications for Healthy Psychological Functioning, Spirituality, and Religion | Center for the Study of World Religions
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study | Translational Psychiatry
Emotions and brain function are altered up to one month after a single high dose of psilocybin | Scientific Reports
Self-reported negative outcomes of psilocybin users: A quantitative textual analysis | PLOS ONE
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects | Neuropsychopharmacology
Psilocybin rescues sociability deficits in an animal model of autism | bioRxiv
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial - Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey | SpringerLink
Psilocybin Therapeutic Research: The Present and Future Paradigm | ACS Medicinal Chemistry Letters
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM
Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial' - eClinicalMedicine
Psilocybin Revisited: The Science Behind the Drug and Its Surprising Therapeutic Potential
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM
Psilocybin mushrooms for psychological and existential distress | The College of Family Physicians of Canada
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study - The Lancet Psychiatry
JoX | Free Full-Text | Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
Psilocybin Relieves Some Treatment-Resistant Depression Cases: Trial | The Scientist Magazine®
Psilocybin Mushrooms: Basic Info | Psycheplants | ICEERS
